Relation of Endothelial Function to Residual Platelet Reactivity After Clopidogrel in Patients With Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 105, Issue 3, 2010, Pages 333-338

  Muller, Olivier ^a   Hamilos, Michalis ^a   Bartunek, Jozef ^a   Ulrichts, Hans ^b   Mangiacapra, Fabio ^a   Holz, Josefin Beate ^b   Ntalianis, Argyrios ^a   Trana, Catalina ^a   Dierickx, Karen ^a   Vercruysse, Kristof ^b   De Bruyne, Bernard ^a   Wijns, William ^a   Barbato, Emanuele ^a  

^a OLV HOSPITAL   (Belgium)

^b ABLYNX NV   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; PADGEM PROTEIN; RISTOCETIN; TROPONIN T; VON WILLEBRAND FACTOR;

ADVERSE OUTCOME; AGED; ANGIOCARDIOGRAPHY; ARTERY; ARTICLE; ASSAY; ATHEROSCLEROSIS; BLOOD SAMPLING; CORONARY ARTERY DISEASE; ENDOSCORE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; POINT OF CARE TESTING; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; STABLE ANGINA PECTORIS; THROMBOCYTE; TONOMETRY; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; BIOLOGICAL MARKERS; BLOOD PLATELETS; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MANOMETRY; MIDDLE AGED; P-SELECTIN; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TICLOPIDINE; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME; TROPONIN T;

EID: 74049160028     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.09.033     Document Type: Article

References (30)

1. Mehta S.R., Yusuf S., Peters R.J., Bertrand M.E., Lewis B.S., Natarajan M.K., Malmberg K., Rupprecht H., Zhao F., Chrolavicius S., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 (2001) 527-533
2. Snoep J.D., Hovens M.M., Eikenboom J.C., Van Der Bom J.G., Jukema J.W., and Huisman M.V. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. Am Heart J 154 (2007) 221-231
3. Patti G., Nusca A., Mangiacapra F., Gatto L., D'Ambrosio A., and Di Sciascio G. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. J Am Coll Cardiol 52 (2008) 1128-1133
4. Price M.J., Endemann S., Gollapudi R.R., Valencia R., Stinis C.T., Levisay J.P., Ernst A., Sawhney N.S., Schatz R.A., and Teirstein P.S. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 29 (2008) 992-1000
5. Collet J.P., Hulot J.S., Pena A., Villard E., Esteve J.B., Silvain J., Payot L., Brugier D., Cayla G., Beygui F., Bensimon G., Funck-Brentano C., and Montalescot G. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet 373 (2009) 309-317
6. Simon T., Verstuyft C., Mary-Krause M., Quteineh L., Drouet E., Meneveau N., Steg P.G., Ferrieres J., Danchin N., and Becquemont L. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 360 (2009) 363-375
7. Angiolillo D.J., Fernandez-Ortiz A., Bernardo E., Alfonso F., Macaya C., Bass T.A., and Costa M.A. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol 49 (2007) 1505-1516
8. Gurbel P.A., Bliden K.P., Hiatt B.L., and O'Connor C.M. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 107 (2003) 2908-2913
9. Davi G., and Patrono C. Platelet activation and atherothrombosis. N Engl J Med 357 (2007) 2482-2494
10. Keating F.K., Whitaker D.A., Kabbani S.S., Ricci M.A., Sobel B.E., and Schneider D.J. Relation of augmented platelet reactivity to the magnitude of distribution of atherosclerosis. Am J Cardiol 94 (2004) 725-728
11. Bonetti P.O., Pumper G.M., Higano S.T., Holmes Jr. D.R., Kuvin J.T., and Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 44 (2004) 2137-2141
12. Hamburg N.M., Keyes M.J., Larson M.G., Vasan R.S., Schnabel R., Pryde M.M., Mitchell G.F., Sheffy J., Vita J.A., and Benjamin E.J. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham heart study. Circulation 117 (2008) 2467-2474
13. Cuisset T., Hamilos M., Sarma J., Sarno G., Wyffels E., Vanderheyden M., Barbato E., Bartunek J., De Bruyne B., and Wijns W. Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris. Am J Cardiol 101 (2008) 1700-1703
14. Crandall J.P., Shamoon H., Cohen H.W., Reid M., Gajavelli S., Trandafirescu G., Tabatabaie V., and Barzilai N. Post-challenge hyperglycemia in older adults is associated with increased cardiovascular risk profile. J Clin Endocrinol Metab 94 (2009) 1595-1601
15. Kuvin J.T., Patel A.R., Sliney K.A., Pandian N.G., Sheffy J., Schnall R.P., Karas R.H., and Udelson J.E. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. Am Heart J 146 (2003) 168-174
16. Blann A.D., Nadar S.K., and Lip G.Y. The adhesion molecule p-selectin and cardiovascular disease. Eur Heart J 24 (2003) 2166-2179
17. Conlan M.G., Folsom A.R., Finch A., Davis C.E., Sorlie P., Marcucci G., and Wu K.K. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis: the Atherosclerosis Risk In Communities (ARIC) study. Thromb Haemost 70 (1993) 380-385
18. Farkas K., Kolossvary E., Jarai Z., Nemcsik J., and Farsang C. Non-invasive assessment of microvascular endothelial function by laser Doppler flowmetry in patients with essential hypertension. Atherosclerosis 173 (2004) 97-102
19. Ruggeri Z.M., and Ware J. The structure and function of von Willebrand factor. Thromb Haemost 67 (1992) 594-599
20. Armstrong E.J., Morrow D.A., and Sabatine M.S. Inflammatory biomarkers in acute coronary syndromes. Part IV: matrix metalloproteinases and biomarkers of platelet activation. Circulation 113 (2006) e382-e385
21. Kappelmayer J., Nagy Jr. B., Miszti-Blasius K., Hevessy Z., and Setiadi H. The emerging value of P-selectin as a disease marker. Clin Chem Lab Med 42 (2004) 475-486
22. Matetzky S., Shenkman B., Guetta V., Shechter M., Bienart R., Goldenberg I., Novikov I., Pres H., Savion N., Varon D., and Hod H. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109 (2004) 3171-3175
23. Furman M.I., Benoit S.E., Barnard M.R., Valeri C.R., Borbone M.L., Becker R.C., Hechtman H.B., and Michelson A.D. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 31 (1998) 352-358
24. Koyama H., Maeno T., Fukumoto S., Shoji T., Yamane T., Yokoyama H., Emoto M., Tahara H., Inaba M., Hino M., Shioi A., Miki T., and Nishizawa Y. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 108 (2003) 524-529
25. Lee P.Y., Chen W.H., Ng W., Cheng X., Kwok J.Y., Tse H.F., and Lau C.P. Low-dose aspirin increases aspirin resistance in patients with coronary artery disease. Am J Med 118 (2005) 723-727
26. Thygesen K., Alpert J.S., White H.D., Jaffe A.S., Apple F.S., Galvani M., Katus H.A., Newby L.K., Ravkilde J., Chaitman B., Clemmensen P.M., Dellborg M., Hod H., Porela P., Underwood R., Bax J.J., Beller G.A., Bonow R., Van der Wall E.E., Bassand J.P., Wijns W., Ferguson T.B., Steg P.G., Uretsky B.F., Williams D.O., Armstrong P.W., Antman E.M., Fox K.A., Hamm C.W., Ohman E.M., Simoons M.L., Poole-Wilson P.A., Gurfinkel E.P., Lopez-Sendon J.L., Pais P., Mendis S., Zhu J.R., Wallentin L.C., Fernandez-Aviles F., Fox K.M., Parkhomenko A.N., Priori S.G., Tendera M., Voipio-Pulkki L.M., Vahanian A., Camm A.J., De Caterina R., Dean V., Dickstein K., Filippatos G., Funck-Brentano C., Hellemans I., Kristensen S.D., McGregor K., Sechtem U., Silber S., Widimsky P., Zamorano J.L., Morais J., Brener S., Harrington R., Morrow D., Lim M., Martinez-Rios M.A., Steinhubl S., Levine G.N., Gibler W.B., Goff D., Tubaro M., Dudek D., and Al-Attar N. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
27. Prasad A., Singh M., Lerman A., Lennon R.J., Holmes Jr. D.R., and Rihal C.S. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol 48 (2006) 1765-1770
28. Bates E.R. Ischemic complications after percutaneous transluminal coronary angioplasty. Am J Med 108 (2000) 309-316
29. Akcakoyun M., Kargin R., Tanalp A.C., Pala S., Ozveren O., Akcay M., Barutcu I., and Kirma C. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events and restenosis in patients undergoing coronary stent implantation: a prospective study. Coron Artery Dis 19 (2008) 337-343
30. Horvath B., Hegedus D., Szapary L., Marton Z., Alexy T., Koltai K., Gyevnar Z., Juricskay I., Toth K., and Kesmarky G. [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients]. Orv Hetil 144 (2003) 2471-2476